Hypotension in Neonates

Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00882284

Enrollment

820

Registered

2009-04-16

Start date

2009-04-30

Completion date

2009-12-31

Last updated

2019-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Hypotension, Infant, Newborn

Keywords

NICHD Neonatal Research Network, Blood Pressure Management

Brief summary

This observational study collects information on the current incidence and management of hypotension in babies born at term or late preterm that are admitted to Neonatal Intensive Care Units (NICUs) within the Neonatal Research Network (NRN). Participants include all newborn infants born at 34 0/7 weeks gestation or greater who are admitted to NICU Network centers and intubated and mechanically ventilated at less than 72 hours of age. The information gathered will provide a framework for the design of a potential randomized controlled trial for the treatment of hypotension in neonates. This observational study is for a time-limited enrollment period of 4-6 months; NRN centers will continue to enroll until at least 50 patients are enrolled per center (for approximately 800-1,000 subjects total).

Detailed description

An estimated 30-50 percent of infants born at or near term who require ventilation for respiratory failure also receive therapy for hypotension and associated clinical instability, such as poor urine output, poor circulation to the tissues, and metabolic acidosis (a pH imbalance in which the body accumulates too much acid). Emerging evidence, although limited, suggests that the underlying cause of hypotension in many of these infants is that their adrenal glands do not produce adequate amounts of cortisol. This observational study is to determine the current incidence and management of hypotension in infants born at least 34 0/7 weeks gestation who are intubated and mechanically ventilated at less than 72 hours of age. The goal is to define a target population for a potential randomized controlled trial for the treatment of hypotension in such infants. In this study, 16 NICHD Neonatal Research Network centers are enrolling at least 50 infants each, collecting basic demographic and baseline data on the mother and baby. In those infants treated for hypotension, data is collected on the dose, duration, and type of therapy, age and blood pressure at the time therapy is started, and the indication for the therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 72 Hours

Healthy volunteers

Inclusion criteria

* ≥34 0/7 weeks gestational age * Intubated and mechanically ventilated within 72 hours of postnatal age

Exclusion criteria

* major congenital heart disease * acute hypotension resulting directly from known acute maternal and/or fetal hemorrhage within 24 hours prior to delivery * pituitary hypoplasia * congenital adrenal hyperplasia * known chromosomal disorders

Design outcomes

Primary

Measure	Time frame
Prevalence of Hypotension in infants	< 72 hours of age until hospital discharge

Secondary

Measure	Time frame
Management of hypotension in infants	< 72 hours of age through resolution of hypotension
Short-term outcomes, including: vasopressor/inotrope exposure, death, time to full nipple feedings, duration of ventilation, and length of NICU stay	< 72 hours of age until hospital discharge

Countries

United States

Outcome results